Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Second U.S. Independent Laboratory Confirms That Oculus Innovative Sciences' Microcyn(R) Technology Effective At Inactivating H1N1 Swine Flu
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of Microcyn® Technology at inactivating the H1NI Swine Influenza A. In a virucidal time-kill suspension test conducted by an independent laboratory, BioScience Laboratories, Inc., the specific Microcyn Technology formulation reduced infectivity of the swine flu virus by 4.00log10 (99.99%) reduction after just 30-seconds exposure. BioScience Laboratories, working in cooperation with the U.S. Department of Agriculture, received formal approval to acquire, house and evaluate the specific swine influenza virus in April 2009.
generic viagra online
SYMBICORT(R) Added To Tiotropium Provided Clinically Significant Benefits For Patients With Severe COPD
Data presented at this year"s American Thoracic Society (ATS) congress, demonstrated that SYMBICORT® (budesonide/formoterol-TURBUHALER®, a dry powder inhaler) added to SpirivaTM (tiotropium) provided greater clinical improvements than tiotropium alone over a 12-week treatment period.1,2
News of the day
Green Tea Slows Down Prostate Cancer Progression Significantly
A study carried out by researchers in the Feist-Weiller Cancer Center, LSU Health Sciences Center-Shreveport, USA, found that men with prostate cancer who consumed the active compounds found in green tea had considerable reduction in serum markers predictive of prostate cancer progression. The study has been published in Cancer Prevention Research, an American Association for Cancer Research journal.
Public Health

Maryland Stem Cell Research Commission

What The Maryland Stem Cell Research Commission (Commission) will hold a regular meeting. Part of this meeting may be conducted in closed session (see "Note"). During this meeting, the Commission is requesting to hear comments from the public. Those wishing to address the Commission on the topic of stem cell research in the State of Maryland must first coordinate a speaking time with Commission administration. Members of the public who wish to be heard should email mscrfinfo@marylandtedco.org. Established as an independent unit within the Maryland Technology Development Corporation (TEDCO), the Commission has set up criteria, standards and requirements to administer the Maryland Stem Cell Research Fund in accordance with the Maryland Stem Cell Research Act of 2006. The Maryland Stem Cell Research Fund has been established to promote state-funded stem cell research. With a $15.4 million budget for FY 2010, the Commission will support grants to public and private entities in the State. For more information about the Maryland Stem Cell Research Fund and a list of Commission members, please visit http://www.mscrf.org. Note The Commission may, in open session, follow the required procedures to go into closed session, which will be limited to matters that are permissibly discussed in closed session under the Maryland Open Meetings Act. For more information, please refer to http://www.oag.state.md.us/opengov/index.htm. When Thursday, June 4, 2009 Time 2 p.m. - 5 p.m. Where UMB BioPark - Building 2 Conference Room 801 West Baltimore Street Baltimore, MD 21201 Directions Visit http://www.umbbiopark.com/contact.aspx?details=0 for directions. The parking garage is located on West Baltimore Street. Maryland Stem Cell Research Fund


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009